Nov
DEC
Jan
19
2014
2015
2016
1 captures
19 Dec 15 - 19 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Featured Articles
Frugal Innovation: The Future of Cardiovascular Medicine
Clinical Trial Highlights
The FREEDOM Trial: CABG Superior to PCI in Diabetic Patients with CAD
Assessment of Chelation Therapy: The TACT Trial
OPERA: Omega-3 Fatty Acids Fail to Prevent Postoperative Atrial Fibrillation
Multivitamins for the Prevention of Cardiovascular Disease in Men
Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic AF: Results of the FORWARD Trial
ASPIRE: Using Aspirin to Prevent Recurrence of VTE
First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndrome Trial: The Trilogy ACS-Platelet Function Substudy
Human Monoclonal Antibody for PCSK9 Lowers Cholesterol and Is Well Tolerated
Effects of 12 Weeks of Treatment with RN316 (PF-04950615) in Hypercholesterolemic Subjects on High and Maximal Dose Statins
Dalcetrapib in Patients with Recent Acute Coronary Syndrome
MADIT-RIT: ICD Programming Change Reduces Inappropriate Therapy and All-Cause Mortality
Serelaxin as a Novel Treatment for Acute Heart Failure: Results of the RELAX-AHF Trial
ARCTIC: Randomized Trial of Bedside Platelet Function Monitoring
CARRESS-HF: Ultrafiltration Not Superior to Pharmacologic Therapy in the Treatment of Acute Heart Failure
Long-Term Dabigatran Extension Study for Stroke Prevention in Treatment for Atrial Fibrillation
Impact of LX4211 on Cardiovascular Risk Factors in Type 2 Diabetes
Selected Updates
Cardiovascular Innovations: The Future is Now
Balancing Bleeding and Ischemic Risk in the Acute and Long-Term Setting
Back to top
Previous
Next
Search for this keyword